loading
Precedente Chiudi:
$10.36
Aprire:
$10.4
Volume 24 ore:
737.72K
Relative Volume:
0.47
Capitalizzazione di mercato:
$3.30B
Reddito:
$2.68B
Utile/perdita netta:
$-184.45M
Rapporto P/E:
-15.43
EPS:
-0.6805
Flusso di cassa netto:
$229.23M
1 W Prestazione:
+1.11%
1M Prestazione:
+7.87%
6M Prestazione:
+50.15%
1 anno Prestazione:
+21.20%
Intervallo 1D:
Value
$10.32
$10.50
Intervallo di 1 settimana:
Value
$10.26
$10.68
Portata 52W:
Value
$6.685
$10.68

Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile

Name
Nome
Amneal Pharmaceuticals Inc
Name
Telefono
908-947-3120
Name
Indirizzo
400 Crossing Boulevard, 3rd Floor, Bridgewater
Name
Dipendente
5,210
Name
Cinguettio
@amnealpharma
Name
Prossima data di guadagno
2025-05-02
Name
Ultimi documenti SEC
Name
AMRX's Discussions on Twitter

Confronta AMRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
AMRX
Amneal Pharmaceuticals Inc
10.49 3.25B 2.68B -184.45M 229.23M -0.6805
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
143.91 63.27B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.33 45.67B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.04 39.27B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.16 23.02B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
450.26 20.66B 3.08B 1.24B 1.07B 25.61

Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-06 Iniziato Goldman Buy
2025-02-24 Aggiornamento JP Morgan Neutral → Overweight
2024-09-06 Aggiornamento JP Morgan Underweight → Neutral
2021-04-07 Ripresa RBC Capital Mkts Sector Perform
2021-03-08 Aggiornamento Goldman Sell → Buy
2020-12-14 Aggiornamento Barclays Equal Weight → Overweight
2020-12-14 Aggiornamento Guggenheim Neutral → Buy
2020-07-27 Iniziato Goldman Sell
2020-05-12 Aggiornamento Guggenheim Sell → Neutral
2019-12-12 Downgrade Raymond James Outperform → Mkt Perform
2019-11-12 Downgrade JP Morgan Neutral → Underweight
2019-11-07 Downgrade SVB Leerink Outperform → Mkt Perform
2019-07-22 Aggiornamento SVB Leerink Mkt Perform → Outperform
2019-07-11 Downgrade RBC Capital Mkts Outperform → Sector Perform
2019-07-08 Aggiornamento Piper Jaffray Neutral → Overweight
2019-06-11 Iniziato Barclays Equal Weight
2019-05-21 Aggiornamento Raymond James Mkt Perform → Strong Buy
2019-03-20 Iniziato SunTrust Buy
2019-03-08 Downgrade SVB Leerink Outperform → Mkt Perform
2018-12-14 Downgrade Morgan Stanley Overweight → Equal-Weight
2018-10-16 Downgrade SunTrust Buy → Hold
2018-08-13 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2018-07-23 Iniziato Morgan Stanley Overweight
2018-06-22 Iniziato B. Riley FBR, Inc. Buy
Mostra tutto

Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie

pulisher
11:04 AM

Amneal Pharmaceuticals, Inc. (AMRX) Files BLA for XOLAIR® Biosimilar, Targets Multi-Billion-Dollar Market - MSN

11:04 AM
pulisher
Oct 07, 2025

Amneal Pharmaceuticals Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo

Oct 07, 2025
pulisher
Oct 07, 2025

Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now? - Yahoo Finance

Oct 07, 2025
pulisher
Oct 07, 2025

Amneal Pharmaceuticals (NASDAQ:AMRX) Increases 6.9% This Week, Taking Three-year Gains to 420% - 富途牛牛

Oct 07, 2025
pulisher
Oct 06, 2025

Amneal Pharmaceuticals Hits New 52-Week High of $10.67 - Markets Mojo

Oct 06, 2025
pulisher
Oct 06, 2025

Will Amneal Pharmaceuticals Inc. price bounce be sustainableJuly 2025 Market Mood & AI Driven Stock Price Forecasts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Measuring Amneal Pharmaceuticals Inc.’s beta against major indicesJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Take the Zacks Approach to Beat the Markets: Amneal Pharmaceuticals, Leidos & Vishay Precision in Focus - Nasdaq

Oct 06, 2025
pulisher
Oct 06, 2025

Kashiv Biosciences Announces Submission of Biologics License Application to U.S. FDA and Acceptance of Market Authorization Application by European Medicines Agency for ADL-018, a Proposed Biosimilar to XOLAIR® (omalizumab) - Stock Titan

Oct 06, 2025
pulisher
Oct 06, 2025

Applying Wyckoff theory to Amneal Pharmaceuticals Inc. stockJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Reversal indicators forming on Amneal Pharmaceuticals Inc. stockEarnings Trend Report & Expert Approved Momentum Ideas - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is it time to cut losses on Amneal Pharmaceuticals Inc.Quarterly Portfolio Review & Proven Capital Preservation Methods - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Using Python tools to backtest Amneal Pharmaceuticals Inc. strategies2025 Technical Overview & Expert Verified Stock Movement Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Sentiment analysis tools applied to Amneal Pharmaceuticals Inc.Portfolio Risk Summary & High Win Rate Trade Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Technical analysis overview for Amneal Pharmaceuticals Inc. stock2025 Price Momentum & Low Risk Entry Point Guides - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How to read the order book for Amneal Pharmaceuticals Inc.Trade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will breakout in Amneal Pharmaceuticals Inc. lead to full recoveryGap Down & Comprehensive Market Scan Insights - newser.com

Oct 05, 2025
pulisher
Oct 04, 2025

Amneal Pharmaceuticals Hits New 52-Week High of $10.43 - Markets Mojo

Oct 04, 2025
pulisher
Oct 03, 2025

What to expect from Amneal Pharmaceuticals Inc. in the next 30 daysQuarterly Market Review & Accurate Buy Signal Notifications - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is Amneal Pharmaceuticals Inc. stock cheap compared to fundamentalsEarnings Growth Report & Safe Entry Zone Identification - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Chart based exit strategy for Amneal Pharmaceuticals Inc.Market Volume Summary & Smart Investment Allocation Insights - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

What analysts say about Amneal Pharmaceuticals Inc stockGap Up/Gap Down Analysis & Free Take Advantage Of Momentum - earlytimes.in

Oct 02, 2025
pulisher
Oct 02, 2025

Are Medical Stocks Lagging Amneal Pharmaceuticals (AMRX) This Year? - sharewise.com

Oct 02, 2025
pulisher
Oct 02, 2025

3 Lesser-Known Healthcare Names With Major Upside in Store - sharewise.com

Oct 02, 2025
pulisher
Oct 02, 2025

3 Lesser-Known Healthcare Names With Major Upside in Store - Investing.com

Oct 02, 2025
pulisher
Oct 01, 2025

Amneal Pharmaceuticals stock hits 52-week high at $10.36 By Investing.com - Investing.com Canada

Oct 01, 2025
pulisher
Oct 01, 2025

Amneal Pharmaceuticals stock hits 52-week high at $10.36 - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 09:03:57 - newser.com

Oct 01, 2025
pulisher
Sep 30, 2025

Amneal to Report Third Quarter 2025 Results on October 30, 2025 - The Manila Times

Sep 30, 2025
pulisher
Sep 30, 2025

Global Biopharma Amneal Pharmaceuticals Schedules Q3 2025 Financial Results and Investor Conference - Stock Titan

Sep 30, 2025
pulisher
Sep 30, 2025

Amneal Files Xolair Biosimilar In US ‘Earlier Than Expected’ - insights.citeline.com

Sep 30, 2025

Amneal Pharmaceuticals Inc Azioni (AMRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.43
price down icon 0.12%
$9.98
price down icon 1.63%
drug_manufacturers_specialty_generic RDY
$13.99
price down icon 0.25%
$58.05
price down icon 0.19%
$139.57
price up icon 1.88%
$450.26
price down icon 1.53%
Capitalizzazione:     |  Volume (24 ore):